AnGes, Inc.
Initiatives to Enhance Corporate Value through Business Partnership with Growth Partners
Through a business partnership with GP, accelerate overseas expansion and maximize the value of the drug discovery pipeline. In addition to capital provision, receive hands-on support including management support, business development, and DX promotion, and pursue strengthened domestic and international licensing and partnerships and optimization of the business portfolio.
Key Figures
- Key Figure 1: Unknown (no numerical information provided in the PDF)
- Key Figure 2: Unknown (no numerical information provided in the PDF)
- Key Figure 3: Unknown (no numerical information provided in the PDF)
AI要約
Overview of the Partnership
AnGes, Inc. has started a business partnership with Growth Partners Co., Ltd. (GP). GP provides hands-on services that include not only capital provision but also management support, business development support, M&A support, DX promotion, and alliance support. Through this, AnGes aims to strengthen licensing activities and business partnerships domestically and internationally, leverage the drug discovery pipeline, and achieve medium- to long-term enhancement of corporate value. The company is currently exchanging opinions on business contents and organizational management and conducting cross-organizational evaluation of GP.
Future Outlook and Policy
Going forward, in collaboration with GP, AnGes will strengthen domestic and international licensing and partnerships, explore new alliance opportunities, optimize the business portfolio, promote business development with overseas markets in view, and enhance IR activities and measures to increase corporate value. In particular, the company aims to promptly realize a sales partner agreement for the HGF gene therapy product and work to maximize the value of the drug discovery pipeline and owned businesses.
AnGes, Inc.
Company overview · Stock price · Financial data · All IR
